Today, innovations are revolutionizing the entire healthcare development and commercialization landscape and the need of the hour is, strategies that pave the way for a smarter and more patient centric tomorrow.
With this background, DIA India is excited to bring you an insightful discussion on the latest innovations and the impact of real world evidence and digital transformation on drug safety, pharmacovigilance, risk management and post marketing surveillance.
Who should attend?
- Pharmacovigilance And Drug Safety
- Risk Management
- Pharmacovigilance Compliance
- Regulatory Affairs
- Medical Affairs
- Late Phase Professionals Conducting PMS, Observational And Non-Interventional Studies
- Real World Data And Real World Evidence
- Technology Professionals
Moin Don • CEO and President
PVCON Pharmacovigilance Consulting Services, India
Krishna Bahadursingh, MD • Head of Corporate and Product Strategy (global) and Sales Lead for Japan, Asia
Rxlogix – Japan, Japan
Shirish Dattatraya Sherlekar, MD • Global Head, Life Sciences Practice
Tata Consultancy Services, United States
Chitra Lele, PhD • Chief Scientific Officer
Sciformix Technologies Pvt. Ltd., India
J Vijay Venkatraman, MD, MBA • Managing Director & CEO
Oviya MedSafe Pvt Ltd, India
Anju Agarwal • Head of Drug Safety
Advanz Pharma, United Kingdom
Avinash Kakade • Senior Director